A Secretory Vesicle Failure in Parkinson's Disease Occurs in Human Platelets. Issue 5 (15th March 2022)

• Record Type: Journal Article
• Authors: Montenegro, Pablo; Pueyo, Mercedes; Lorenzo, Jesús Norelis; Villar‐Martinez, María Dolores; Alayón, Antonio; Carrillo, Francisco; Borges, Ricardo
• Is Part Of: Annals of neurology. Volume 91:Issue 5(2022)
• Page Start: 697
• Page End: 703
• Publication Date: 2022-03-15
• Subjects: Neurology -- Periodicals; Pediatric neurology -- Periodicals; Nervous system -- Surgery -- Periodicals; 616.8
• DOI: 10.1002/ana.26335
• Languages: English
• ISSNs: 0364-5134

Abstract

Abstract : Objective: The presence of elevated dopamine (DA) and its major metabolites in the cytosol of neurons has been associated with their vulnerability in Parkinson's disease (PD). Over 99% of the cell's amines are confined to secretory vesicles (SVs), making these structures fundamental in the regulation of cytosolic DA levels. SVs of platelets use similar, if not the same mechanisms to accumulate serotonin in SVs as dopaminergic neurons do to store DA. Hence, any functional defects in platelets probably mirrors events in DA neurons. Methods: We have isolated fresh platelets from the blood of 75 PD patients, 116 matched controls and 24 patients with Parkinsonism, assaying serotonin handling (basal content, accumulation, secretion and spontaneous leakage). Results: We found a dramatic decrease in the serotonin content and uptake by SVs, as well as decreased thrombin‐induced release by platelets from PD patients but not in those from most Parkinsonism cases. Platelets from PD patients also failed to retain serotonin in SVs. Interpretation: These findings indicate a functional impairment in the handling of amines by SVs in PD patients. This defect may serve as a biomarker of PD, and the approach described here may be potentially used for the subclinical detection of PD and to establish a platform to assay disease modifying drugs. ANN NEUROL 2022